Literature DB >> 18821462

Experience of IUD/IUS insertions and clinical performance in nulliparous women--a pilot study.

Andrea Brockmeyer1, Meera Kishen, Anne Webb.   

Abstract

OBJECTIVES: To assess experience of insertion and use, by nulliparous women, of intrauterine devices (IUDs) and intrauterine systems (IUSs) and the feasibility of a large comparative study.
METHODS: Prospective pilot study of women attending for interval insertion of IUD/IUS or emergency IUD. Problems and experience of the procedure were noted. At three months and one year continuation rates, satisfaction levels and problems were recorded. Case notes were reviewed for non-responders.
RESULTS: Between May and October 2005, 117 nulliparous women were recruited. Nine had an IUS inserted, and 104 an IUD. Despite a reasonable level of pain at insertion most women gave broadly positive descriptions of the procedure. At one year, 65 women were known to still have their original device. Fifteen had it removed; in six women it was expelled. The satisfaction score was high. There were no pregnancies or perforations.
CONCLUSIONS: Insertion of IUD/IUS was well tolerated by the majority. Continuation and satisfaction rates were high. The IUD/IUS should be offered to nulliparous women as part of the full contraceptive menu. The ease of recruitment in this pilot study suggests that a larger study is feasible.

Entities:  

Mesh:

Year:  2008        PMID: 18821462     DOI: 10.1080/02699200802253706

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  13 in total

Review 1.  Challenges in the gynecologic care of premenopausal women with breast cancer.

Authors:  Jamie N Bakkum-Gamez; Shannon K Laughlin; Jani R Jensen; Clement O Akogyeram; Sandhya Pruthi
Journal:  Mayo Clin Proc       Date:  2011-02-09       Impact factor: 7.616

2.  Failed IUD insertions in community practice: an under-recognized problem?

Authors:  Amna I Dermish; David K Turok; Janet C Jacobson; Marie E S Flores; Molly McFadden; Kathy Burke
Journal:  Contraception       Date:  2012-09-11       Impact factor: 3.375

Review 3.  Efficacy and safety of long-acting reversible contraception.

Authors:  Amy Stoddard; Colleen McNicholas; Jeffrey F Peipert
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

Review 4.  Long-acting reversible contraception for adolescents.

Authors:  Colleen McNicholas; Jeffrey F Peipert
Journal:  Curr Opin Obstet Gynecol       Date:  2012-10       Impact factor: 1.927

Review 5.  Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives.

Authors:  Luis Bahamondes; Diana Mansour; Christian Fiala; Andrew M Kaunitz; Kristina Gemzell-Danielsson
Journal:  J Fam Plann Reprod Health Care       Date:  2013-09-27

6.  Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study.

Authors:  Dirk Wildemeersch; Sohela Jandi; Ansgar Pett; Kilian Nolte; Thomas Hasskamp; Marc Vrijens
Journal:  Int J Womens Health       Date:  2014-08-06

7.  Intrauterine contraception in nulliparous women: a prospective survey.

Authors:  Alexandra M Hall; Beth A Kutler
Journal:  J Fam Plann Reprod Health Care       Date:  2015-04-08

Review 8.  Management of pain associated with the insertion of intrauterine contraceptives.

Authors:  K Gemzell-Danielsson; D Mansour; C Fiala; A M Kaunitz; L Bahamondes
Journal:  Hum Reprod Update       Date:  2013-05-12       Impact factor: 15.610

Review 9.  Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States.

Authors:  Jennie Yoost
Journal:  Patient Prefer Adherence       Date:  2014-07-03       Impact factor: 2.711

Review 10.  A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women.

Authors:  Kirsten Black; Pamela Lotke; Kai J Buhling; Nikki B Zite
Journal:  Eur J Contracept Reprod Health Care       Date:  2012-07-26       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.